For individuals carrying the APOE4 variant, it is recommended to prioritize DHA in phospholipid form (found in fish roe or krill oil) rather than conventional fish oil, at doses exceeding 2 g per day, to best support mental agility.

noli's read

This recommendation is based on a scientific hypothesis published by researcher Rhonda Patrick in the FASEB Journal. The initial observation is sound: observational studies indicate that APOE4 carriers derive significant benefits from the consumption of whole fish, whereas clinical trials with conventional omega-3 supplements struggle to show effects on their mental clarity. Preclinical research on animal models validates the mechanism: the phospholipid form uses a specific transporter to cross the brain's protective barrier, a route that remains accessible, whereas the transport of conventional DHA appears to be slowed. Nevertheless, asserting that targeted supplementation of more than 2 g per day in this specific form directly protects the human brain is still an extrapolation. Indeed, we lack randomized controlled trials (RCTs) in humans to confirm the superiority of these supplements or the exact dosage for APOE4 carriers. It is a fascinating concept of personalized nutrition that relies on excellent biological logic, though its practical proof must still be formally established.

the sources

1. 1NIH Office of Dietary Supplements 2026
2. 2Manson JE et al. 2019
3. 3foundmyfitness.com/topics